Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366

Rhea-AI Filing Summary

Elevance Health director Ramiro G Peru purchased 1,000 shares of common stock on 2026-07-17 at $366.05 per share. Following this open-market transaction, he directly owns 10,908 shares of Elevance Health, Inc. common stock.

Insider Trade Summary

Net Buyer: 1,000 shares ($366,050)

Net Buy 1 txn

Insider PERU RAMIRO G

Role Director

Bought 1,000 shs ($366K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,000	$366.05	$366K

Holdings After Transaction: Common Stock — 10,908 shares (Direct)

Footnotes (1)

Key Figures

Shares purchased: 1,000 shares Purchase price: $366.05 per share Post-transaction holdings: 10,908 shares

3 metrics

Shares purchased 1,000 shares Common stock bought by director Ramiro G Peru on 2026-07-17

Purchase price $366.05 per share Price paid for Elevance Health common stock on 2026-07-17

Post-transaction holdings 10,908 shares Direct ownership by Ramiro G Peru after the reported transaction

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 03:05 PM Accepted by SEC EDGAR 07/17/2026 - 03:04 PM Learn about SEC filing dates

FAQ

What insider transaction did Elevance Health (ELV) disclose for Ramiro G Peru?

Elevance Health reported that director Ramiro G Peru bought 1,000 shares of common stock on 2026-07-17 at $366.05 per share. This open-market purchase was reported on a Form 4 insider filing and increased his direct holdings in the company.

How many Elevance Health (ELV) shares does Ramiro G Peru hold after this transaction?

After the reported purchase, Ramiro G Peru directly owns 10,908 shares of Elevance Health common stock. This reflects the addition of 1,000 shares acquired on 2026-07-17 in an open-market or private transaction, as shown in the Form 4 filing.

Was the recent ELV insider trade by Ramiro G Peru a buy or a sell?

The reported transaction was a buy. Ramiro G Peru purchased 1,000 shares of Elevance Health common stock at $366.05 per share, classified as a purchase in an open-market or private transaction, with no corresponding sale reported in this Form 4.

At what price did Ramiro G Peru buy Elevance Health (ELV) shares?

He purchased the Elevance Health shares at an average price of $366.05 per share. The Form 4 identifies this as the per-share transaction price for the 1,000 common shares acquired on 2026-07-17 in an open-market or private transaction.

Was Ramiro G Peru’s Elevance Health (ELV) share purchase under a Rule 10b5-1 plan?

The filing indicates the transaction was not reported under a Rule 10b5-1 trading plan. The document’s 10b5-1 checkbox is explicitly unchecked, suggesting the 1,000-share purchase was not executed pursuant to an affirmed pre-arranged trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PERU RAMIRO G

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/17/2026		P		1,000	A	$366.05	10,908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)